Source: http://www.nabp.net/news/south-dakota-news-new-pseudoephedrine-bill-passes-in-legislature/
Timestamp: 2013-05-21 14:03:05
Document Index: 275322196

Matched Legal Cases: ['§34', '§36', '§34', '§36', '§34', '§34', '§34', '§36', '§36']

South Dakota News: New Pseudoephedrine Bill Passes in Legislature - News - National Association of Boards of Pharmacy® (NABP®)
South Dakota News: New Pseudoephedrine Bill Passes in Legislature
April 1, 2006 12:28 pm
Following is the revised pseudoephedrine bill which will go into effect July 1, 2006.
ENTITLED, An Act to revise certain provisions pertaining to the sale, purchasing, and possession of products containing pseudoephedrine or ephedrine.
Section 1. That §34-20D-1 be amended to read as follows: 34-20D-1. No retailer may sell, in a single transaction, more than two packages containing pseudoephedrine or ephedrine as an active ingredient. For purposes of this chapter, the term, retailer, means any person who sells merchandise at retail and from whom original packages of nonprescription drugs are sold or taken to be sold at retail and who is licensed by the Board of Pharmacy to sell nonprescription drugs. This restriction does not apply to any sale made pursuant to a valid prescription drug order prescribed by a practitioner as defined in §36-11-2 with appropriate authority. Any retailer or any employee of a retailer who sells packages containing pseudoephedrine or ephedrine in violation of this section is guilty of a Class 1 misdemeanor.
Section 2. That §34-20D-2 be amended to read as follows: 34-20D-2. No person may purchase, in a single transaction, more than two packages containing pseudoephedrine or ephedrine as an active ingredient. This restriction does not apply to purchases made with a valid prescription drug order prescribed by a practitioner as defined in §36-11-2 with appropriate authority. Any person who purchases packages containing pseudoephedrine or ephedrine in violation of this section is guilty of a Class 1 misdemeanor.
Section 3. That §34-20D-3 be amended to read as follows: 34-20D-3. Any retailer who offers for sale a product containing pseudoephedrine or ephedrine as an active ingredient shall display and offer the product for sale, except as otherwise provided, behind a counter where the public is not permitted or in a locked case so that a customer wanting access to the package must ask a store employee for assistance. The retailer may display or offer for sale without restriction a product containing pseudoephedrine or ephedrine as an active ingredient if the product is displayed using any type of anti-theft device system including an electronic anti-theft device system that utilizes a product tag and detection alarm which prevents the theft of the product.
Section 4. That §34-20D-4 be repealed.
Section 5. That §34-20D-5 be amended to read as follows: 34-20D-5. A retailer shall post notice at the location where a product containing pseudoephedrine or ephedrine as an active ingredient is displayed or offered for sale stating the following: South Dakota law prohibits the sale or purchase of more than two packages containing pseudoephedrine or ephedrine as an active ingredient unless sold or purchased with a valid prescription drug order prescribed by a practitioner as defined in §36-11-2 with appropriate authority.
Section 6. That chapter 34-20D be amended by adding thereto a NEW SECTION to read as follows: If offering for sale a product containing pseudoephedrine or ephedrine as an active ingredient, a retailer shall, before making such a sale, require and make a record of the identification of the person purchasing the product containing pseudoephedrine or ephedrine. For purposes of this section, the term, identification, means a document issued by a governmental agency which contains a description of the person or a photograph of the person, or both, and gives the person’s date of birth, such as a driver’s license, passport, or military identification card. The retailer shall maintain the record of identification, including the purchaser’s name and date of birth. On August 1, 2006, and no later than the fifth day of every month thereafter, the retailer shall send any such records to the Office of the Attorney General. No retailer may use or maintain the record for any private or commercial purpose or disclose the record to any person, except as authorized by law. The retailer shall disclose the record, upon request, to a law enforcement agency for a law enforcement purpose.
No person may possess, receive, or otherwise acquire more than nine grams of ephedrine base, pseudoephedrine base, or phenylpropanolamine base in any product, mixture, or preparation within any 30-day period. This restriction does not apply to any quantity of product, mixture, or preparation obtained pursuant to a valid prescription drug order prescribed by a practitioner as defined in §36-11-2 with appropriate authority.
1. A retail distributor of drug products;
2. A wholesale drug distributor, or its agents;
3. A manufacturer of drug products, or its agents;
4. A pharmacist licensed by the Board of Pharmacy; or
5. A licensed health care professional possessing the drug products in the course of carrying out the profession.
Minnesota News: Methamphetamine Precursors...
South Dakota News: Court Decision